Graham Capital Management, L.P. Pliant Therapeutics, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 15,022 shares of PLRX stock, worth $187,775. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,022Holding current value
$187,775% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$74.7 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$62.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$57.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$43 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$42.5 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $609M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...